retatrutide pros and cons – The New Weight Loss Helper Retatrutide is a new medication being developed by Eli Lilly to help people lose weight. It's like a super version of drugs such as Ozempic Pros and Cons of Retatrutide:

Individuals who might theoretically be candidates for both treatments could include: Men with obesity and hypogonadism , where weight loss is a clinical priority alongside hormone replacement Transgender men on testosterone therapy who also have obesity-related metabolic conditions Individuals enrolled in clinical trials investigating retatrutide's effects on metabolic syndrome, where testosterone use is a pre-existing condition It is important to note that combining an unlicensed investigational drug with a licensed hormone therapy requires careful oversight

"The Association Between Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) and Suicidality: Reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)." Expert Opinion on Drug Safety, 13 Dec

GLP-1R activation suppresses appetite and slows gastric emptying

(Kristensen et al., 2019

health system is whether Medicaid and Medicare are prepared to treat obesity like the chronic disease it is

More research is required to determine the long-term safety and efficacy of both drugs.